Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06824155 | HEAT Trial (HER2 Antibody Therapy With Lutetium-177)(RAD202) | recruiting | Early Phase 1 | 30 | Radiopharm Theranostics, LtdINDUSTRY | 1 | Sep 24, 2026 | clinicaltrials |
| NCT05108298 | Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials | active not recruiting | Early Phase 1 | 500 | ECOG-ACRIN Cancer Research GroupNETWORK | 1 | Sep 4, 2026 | clinicaltrials |
| NCT07793500 | YSCH-01 Via Nebulization in Pulmonary Metastasis of Advanced Solid Tumors and Non-small Cell Lung Cancer (NSCLC) | recruiting | Early Phase 1 | 36 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT04147494 | Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues | active not recruiting | Early Phase 1 | 29 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 21, 2026 | clinicaltrials |
| NCT07595237 | A IIT Study of 177Lu-DOTA-SNA040 | recruiting | Early Phase 1 | 12 | SmartNuclide BiopharmaINDUSTRY | 1 | Aug 21, 2026 | clinicaltrials |
| NCT05733949 | Spatiotemporal Stereotactic Body Radiation Therapy for the Treatment of Patients With Polymetastatic Solid Tumors | recruiting | Early Phase 1 | 20 | City of Hope Medical CenterOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT06184321 | Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion | recruiting | Early Phase 1 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 17, 2026 | clinicaltrials |
| NCT03813615 | Study of the Effects of Pre-surgical Aerobic Exercise on Patients With Solid Tumors | active not recruiting | Early Phase 1 | 60 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT04967833 | A Study of GC101 TIL in Advanced Solid Tumors (TR) | recruiting | Early Phase 1 | 20 | Shanghai Juncell TherapeuticsINDUSTRY | 1 | Aug 5, 2026 | clinicaltrials |
| NCT05087745 | A Clinical Study on TIL for the Treatment of Advanced Solid Tumors | recruiting | Early Phase 1 | 50 | Shanghai Juncell TherapeuticsINDUSTRY | 1 | Aug 5, 2026 | clinicaltrials |
| NCT07680582 | An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors | recruiting | Early Phase 1 | 60 | Ruijin HospitalOTHER | 1 | Aug 3, 2026 | clinicaltrials |
| NCT07741006 | Clinical Evaluation of [68Ga]Ga-ELI411 PET Imaging in Adult Patients With Solid Tumors | enrolling by invitation | Early Phase 1 | 18 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Aug 3, 2026 | clinicaltrials |
| NCT07556653 | Allogeneic WTX-212C in Advanced Solid Tumors(WTX-212C-IIT) | recruiting | Early Phase 1 | 24 | Zhejiang Provincial People's HospitalOTHER | 1 | Jul 14, 2026 | clinicaltrials |
| NCT06824363 | ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu | recruiting | Early Phase 1 | 34 | University of California, IrvineOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT07412665 | A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors. | not yet recruiting | Early Phase 1 | 10 | Beijing Geekgene Technology Co., LTDINDUSTRY | 1 | Jun 25, 2026 | clinicaltrials |
| NCT07657611 | Inhaled mRNA Immunotherapy for Patients With Advanced Lung Cancer or Pulmonary Metastatic Solid Tumors(BMD-PLAT) | not yet recruiting | Early Phase 1 | 60 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 0 | Jun 18, 2026 | clinicaltrials |
| NCT07504445 | Clinical Study on the Efficacy and Safety of CAR-DC in the Treatment of Advanced Solid Tumors | not yet recruiting | Early Phase 1 | 10 | Peking University Shenzhen HospitalOTHER | 1 | Jun 3, 2026 | clinicaltrials |
| NCT07621471 | IL-15 Enhanced NK Cell Therapy for Solid Tumors | not yet recruiting | Early Phase 1 | 12 | Genovn Therapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Jun 2, 2026 | clinicaltrials |
| NCT04541108 | Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies | active not recruiting | Early Phase 1 | 15 | Presage BiosciencesINDUSTRY | 1 | May 22, 2026 | clinicaltrials |
| NCT06400485 | AMT-676 in Patients With Advanced Solid Tumors | recruiting | Early Phase 1 | 24 | Multitude Therapeutics Inc.INDUSTRY | 3 | May 18, 2026 | clinicaltrials |
| NCT07583953 | An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors | not yet recruiting | Early Phase 1 | 50 | Suzhou Abogen Biosciences Co., Ltd.INDUSTRY | 0 | May 13, 2026 | clinicaltrials |
| NCT07577206 | Single Microdose Trial- CXCR4 PET Tracer - Pharmacokinetics and Pharmacodynamics of [68Ga]Ga-R54, a Radiopharmaceutical Directed Toward CXCR4 in Patients With Advanced Solid Neoplasia. | recruiting | Early Phase 1 | 10 | National Cancer Institute, NaplesOTHER | 1 | May 11, 2026 | clinicaltrials |
| NCT07220447 | L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance | recruiting | Early Phase 1 | 50 | City of Hope Medical CenterOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT05645523 | Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors | recruiting | Early Phase 1 | 25 | St. Jude Children's Research HospitalOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT07561437 | NK521 in the Treatment of Malignant Ascites Associated With Advanced Solid Tumors | recruiting | Early Phase 1 | 18 | Base Therapeutics (Shanghai) Co., Ltd.INDUSTRY | 1 | May 1, 2026 | clinicaltrials |
| NCT07505069 | Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors | recruiting | Early Phase 1 | 10 | Nanolattix Biotechnology Co., Ltd.INDUSTRY | 1 | Apr 1, 2026 | clinicaltrials |
| NCT07487597 | Functionally Enhanced ALPP-Targeted Engineered T Cells in Advanced Solid Tumors | recruiting | Early Phase 1 | 24 | TCRCure Biopharma Ltd.INDUSTRY | 1 | Mar 23, 2026 | clinicaltrials |
| NCT07475182 | Exploratory Clinical Study of Targeted Activated DC and CAR-T Therapy in Advanced Solid Cancers | recruiting | Early Phase 1 | 10 | Hainan Cancer HospitalOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT03832569 | Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors | active not recruiting | Early Phase 1 | 17 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT07414316 | A Single-Arm, Open-Label Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors. | recruiting | Early Phase 1 | 10 | Beijing Geekgene Technology Co., LTDINDUSTRY | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07327632 | This is a Multi-Center Study of IBI3026 in Participants With Locally Advanced, Unresectable or Metastatic Solid Tumors | recruiting | Early Phase 1 | 300 | Innovent Biologics Technology Limited (Shanghai R&D Center)INDUSTRY | 1 | Feb 4, 2026 | clinicaltrials |
| NCT07242417 | TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors | recruiting | Early Phase 1 | 30 | Beijing GoBroad HospitalOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07349160 | Safety and Efficacy of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors | recruiting | Early Phase 1 | 36 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT07342738 | TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors | not yet recruiting | Early Phase 1 | 25 | Sun Yat-sen UniversityOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT05868486 | Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer | active not recruiting | Early Phase 1 | 100 | City of Hope Medical CenterOTHER | 1 | Jan 2, 2026 | clinicaltrials |
| NCT06645808 | PET-imaging of Two Vartumabs in Patients With Solid Tumors(VARTUTRACE) | recruiting | Early Phase 1 | 32 | Var2 PharmaceuticalsINDUSTRY | 1 | Dec 29, 2025 | clinicaltrials |
| NCT06488950 | A Study of TIL in Advanced Solid Tumors (DFGD) | recruiting | Early Phase 1 | 30 | Shanghai Juncell TherapeuticsINDUSTRY | 1 | Dec 16, 2025 | clinicaltrials |
| NCT06328686 | Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases | recruiting | Early Phase 1 | 10 | Emory UniversityOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT07106814 | Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors | recruiting | Early Phase 1 | 36 | Anhui Provincial HospitalOTHER_GOV | 1 | Sep 15, 2025 | clinicaltrials |
| NCT06822998 | HF50 in HER-2 Positive and Low-expression Advanced Solid Tumors(HF50) | recruiting | Early Phase 1 | 10 | HighField Biopharmaceuticals CorporationINDUSTRY | 1 | Aug 17, 2025 | clinicaltrials |
| NCT06610227 | A Study of the RNA Tumor Vaccine Targeting MICA/B in Patients With Advanced Solid Tumors | active not recruiting | Early Phase 1 | 18 | NING LIOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT06976931 | Study on the Safe Dosage and Therapeutic Effect of the Drug YY2201 Tablets on Patients With Advanced Cancer | not yet recruiting | Early Phase 1 | 42 | Jiangsu YaYao Biotechnology Co., Ltd.INDUSTRY | 0 | May 16, 2025 | clinicaltrials |
| NCT06951425 | An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of Relapsed/Refractory Solid Tumors | not yet recruiting | Early Phase 1 | 24 | Shanghai Tongji Hospital, Tongji University School of MedicineOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT06497010 | An Exploratory Study of Individualized Neo-antigen mRNA Cancer Vaccine InnoPCV in Advanced Solid Tumor Treatment | recruiting | Early Phase 1 | 40 | The Affiliated Hospital Of Guizhou Medical UniversityOTHER | 1 | May 1, 2025 | clinicaltrials |
| NCT05916248 | Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors | recruiting | Early Phase 1 | 34 | Ruijin HospitalOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT06150365 | Personalized KSX01-TCRT in Patients With Advanced Solid Tumors | recruiting | Early Phase 1 | 12 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT06825455 | Allogeneic B7H3 CAR-γδT Cell Therapy for Advanced Solid Tumors | not yet recruiting | Early Phase 1 | 18 | Peking UniversityOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT06713148 | Study on the Safety and Efficacy of Intratumoral Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors | not yet recruiting | Early Phase 1 | 42 | Fudan UniversityOTHER | 0 | Feb 6, 2025 | clinicaltrials |
| NCT06718946 | Study on the Safety and Efficacy of Intravenous Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors | recruiting | Early Phase 1 | 38 | Fudan UniversityOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT06697665 | An Exploratory Clinical Study to Evaluate the Safety, Tolerability, Immune Response and Preliminary Efficacy of LM103 Injection in Combination With PD-1 in Patients With Advanced Solid Tumours | recruiting | Early Phase 1 | 10 | Suzhou BlueHorse Therapeutics Co., Ltd.INDUSTRY | 1 | Nov 20, 2024 | clinicaltrials |
Data updated 4 days agoSource updated Sep 24, 2026source: clinicaltrials